Martin Welschof of Opsona Therapeutics
joined us for World Orphan Drug Congress USA 2015 to present about '
Sending the Right Signals to the Immune System'.
Download the presentation now to understand more about:
-
The value of targeting TLRs
-
Opsona's lead compound OPN-305
-
Efficacy: convincing data in pre-clinical studies
-
OPN-305 Overall Clinical Development Strategy
...and
much
more!
Get your copy here!
To find out more about
Opsona Therapeutics and OPN-305
, join us at
World Orphan Drug Congress USA 2016 April 20-22
in Washington, DC.